2 studies found for:    9236949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Levetiracetam for Alzheimer's Disease-Associated Epileptiform Activity
Condition: Early-onset Alzheimer's Disease
Intervention: Drug: levetiracetam
2 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray

Indicates status has not been verified in more than two years